• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制品中表面诱导的蛋白质聚集和颗粒形成:对机制、检测及缓解策略的当前认识

Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies.

作者信息

Kopp Marie R G, Grigolato Fulvio, Zürcher Dominik, Das Tapan K, Chou Danny, Wuchner Klaus, Arosio Paolo

机构信息

Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.

Bristol Myers Squibb, Warren, NJ, USA.

出版信息

J Pharm Sci. 2023 Feb;112(2):377-385. doi: 10.1016/j.xphs.2022.10.009. Epub 2022 Oct 9.

DOI:10.1016/j.xphs.2022.10.009
PMID:36223809
Abstract

Protein stability against aggregation is a major quality concern for the production of safe and effective biopharmaceuticals. Amongst the different drivers of protein aggregation, increasing evidence indicates that interactions between proteins and interfaces represent a major risk factor for the formation of protein aggregates in aqueous solutions. Potentially harmful surfaces relevant to biologics manufacturing and storage include air-water and silicone oil-water interfaces as well as materials from different processing units, storage containers, and delivery devices. The impact of some of these surfaces, for instance originating from impurities, can be difficult to predict and control. Moreover, aggregate formation may additionally be complicated by the simultaneous presence of interfacial, hydrodynamic and mechanical stresses, whose contributions may be difficult to deconvolute. As a consequence, it remains difficult to identify the key chemical and physical determinants and define appropriate analytical methods to monitor and predict protein instability at these interfaces. In this review, we first discuss the main mechanisms of surface-induced protein aggregation. We then review the types of contact materials identified as potentially harmful or detected as potential triggers of proteinaceous particle formation in formulations and discuss proposed mitigation strategies. Finally, we present current methods to probe surface-induced instabilities, which represent a starting point towards assays that can be implemented in early-stage screening and formulation development of biologics.

摘要

蛋白质抗聚集稳定性是安全有效生物制药生产中的一个主要质量问题。在蛋白质聚集的不同驱动因素中,越来越多的证据表明,蛋白质与界面之间的相互作用是水溶液中蛋白质聚集体形成的一个主要风险因素。与生物制品制造和储存相关的潜在有害表面包括气 - 水和硅油 - 水界面以及来自不同加工单元、储存容器和输送装置的材料。其中一些表面的影响,例如源自杂质的影响,可能难以预测和控制。此外,界面、流体动力学和机械应力的同时存在可能会使聚集体的形成更加复杂,其各自的作用可能难以区分。因此,仍然难以确定关键的化学和物理决定因素,并定义适当的分析方法来监测和预测这些界面处的蛋白质不稳定性。在这篇综述中,我们首先讨论表面诱导蛋白质聚集的主要机制。然后,我们回顾了被确定为潜在有害或在制剂中被检测为蛋白质颗粒形成潜在触发因素的接触材料类型,并讨论了提出的缓解策略。最后,我们介绍了探测表面诱导不稳定性的当前方法,这些方法是朝着可用于生物制品早期筛选和制剂开发的检测方法迈出的第一步。

相似文献

1
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies.生物制品中表面诱导的蛋白质聚集和颗粒形成:对机制、检测及缓解策略的当前认识
J Pharm Sci. 2023 Feb;112(2):377-385. doi: 10.1016/j.xphs.2022.10.009. Epub 2022 Oct 9.
2
Effects of surfaces and leachables on the stability of biopharmaceuticals.表面和可浸出物对生物制药稳定性的影响。
J Pharm Sci. 2011 Oct;100(10):4158-70. doi: 10.1002/jps.22597. Epub 2011 Apr 26.
3
Interfacial Stress in the Development of Biologics: Fundamental Understanding, Current Practice, and Future Perspective.生物制剂研发中的界面应力:基础理解、当前实践和未来展望。
AAPS J. 2019 Mar 26;21(3):44. doi: 10.1208/s12248-019-0312-3.
4
A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability.基于纳米颗粒的表面诱导抗体不稳定性评估方法。
Mol Pharm. 2020 Mar 2;17(3):909-918. doi: 10.1021/acs.molpharmaceut.9b01168. Epub 2020 Jan 27.
5
Surfaces Affect Screening Reliability in Formulation Development of Biologics.表面会影响生物制剂配方开发中的筛选可靠性。
Pharm Res. 2020 Jan 6;37(2):27. doi: 10.1007/s11095-019-2733-1.
6
Introducing the Alba Primary Packaging Platform. Part 1: Particle Release Evaluation.介绍阿尔巴初级包装平台。第1部分:颗粒释放评估。
PDA J Pharm Sci Technol. 2018 Jul-Aug;72(4):382-392. doi: 10.5731/pdajpst.2018.008623. Epub 2018 May 31.
7
Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.表面活性剂对界面蛋白聚集的影响及利用表面张力预测生物制剂的表面活性剂需求。
Mol Pharm. 2021 Jan 4;18(1):148-157. doi: 10.1021/acs.molpharmaceut.0c00743. Epub 2020 Nov 30.
8
Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation.单克隆抗体在硅油-水界面发生凝胶化,随后界面凝胶破裂,导致聚集和颗粒形成。
J Pharm Sci. 2015 Apr;104(4):1282-90. doi: 10.1002/jps.24358. Epub 2015 Jan 30.
9
Protein aggregation and particle formation in prefilled glass syringes.预充式玻璃注射器中的蛋白质聚集和颗粒形成。
J Pharm Sci. 2014 Jun;103(6):1601-12. doi: 10.1002/jps.23973. Epub 2014 Apr 11.
10
Linking aggregation and interfacial properties in monoclonal antibody-surfactant formulations.连接单克隆抗体-表面活性剂配方中的聚集和界面性质。
J Colloid Interface Sci. 2019 Aug 15;550:128-138. doi: 10.1016/j.jcis.2019.04.060. Epub 2019 Apr 23.

引用本文的文献

1
Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations.聚氧乙烯氢化蓖麻油HS 15、弹性蛋白样多肽(ELP)与传统表面活性剂在生物制药制剂中用于抗体稳定化的物理化学比较
Mol Pharm. 2025 Aug 4;22(8):4890-4908. doi: 10.1021/acs.molpharmaceut.5c00519. Epub 2025 Jun 27.
2
Osteoclast-like multinucleated giant cells reinforce polycaprolactone grafts.破骨细胞样多核巨细胞增强聚己内酯移植物。
Front Immunol. 2025 May 21;16:1572238. doi: 10.3389/fimmu.2025.1572238. eCollection 2025.
3
In the flow, how fluid dynamics shapes amyloid formation.
在流动过程中,流体动力学如何塑造淀粉样蛋白的形成。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2504573122. doi: 10.1073/pnas.2504573122. Epub 2025 Apr 15.
4
Biophysical Analysis of Therapeutic Antibodies in the Early Development Pipeline.处于早期研发阶段的治疗性抗体的生物物理分析
Biologics. 2024 Dec 21;18:413-432. doi: 10.2147/BTT.S486345. eCollection 2024.
5
Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation.结合化学显著影响靶向纳米颗粒的毒性和生物分布,由补体激活介导。
Adv Mater. 2025 Feb;37(5):e2409945. doi: 10.1002/adma.202409945. Epub 2024 Dec 11.
6
Computational investigation of missense somatic mutations in cancer and potential links to pH-dependence and proteostasis.计算研究癌症中的错义体细胞突变及其与 pH 依赖性和蛋白质平衡的潜在联系。
PLoS One. 2024 Nov 19;19(11):e0314022. doi: 10.1371/journal.pone.0314022. eCollection 2024.
7
Mitigation Strategies against Antibody Aggregation Induced by Oleic Acid in Liquid Formulations.针对液态制剂中油酸诱导的抗体聚集的缓解策略。
Mol Pharm. 2024 Nov 4;21(11):5761-5771. doi: 10.1021/acs.molpharmaceut.4c00754. Epub 2024 Oct 23.
8
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
9
Study of Monoclonal Antibody Aggregation at the Air-Liquid Interface under Flow by ATR-FTIR Spectroscopic Imaging.在流动条件下通过衰减全反射傅里叶变换红外光谱成像研究单克隆抗体在气液界面的聚集。
Langmuir. 2024 Mar 19;40(11):5858-5868. doi: 10.1021/acs.langmuir.3c03730. Epub 2024 Mar 6.
10
Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry.制药行业中基于蛋白质的治疗药物的稳定性挑战与聚集
RSC Adv. 2023 Dec 11;13(51):35947-35963. doi: 10.1039/d3ra06476j. eCollection 2023 Dec 8.